PDCD1 and colonic neoplasm: Gordon et al. found that the phagocytic potency of PD-1+ macrophages is rescued by the inhibition of PD-1/PD-L1 activity, which prolongs survival in preclinical colon cancer models in a macrophage dependent manner (Gordon et al., 2017; Li CW.